UCB
Novartis’ Cosentyx Clinches First Approval for Hidradenitis Suppurativa Treatment
Anika Sharma
Novartis’ Cosentyx has gained an early lead in the field of hidradenitis suppurativa (HS), a painful skin condition, potentially giving ...
UCBās Swiss plant gets Form 483 from FDA over quality and records
Anika Sharma
UCB Farchim, a subsidiary of Belgian pharmaceutical company UCB, is facing regulatory scrutiny from the FDA. The FDA recently issued ...
Bimzelx, a potential blockbuster for psoriasis, clears FDA approval after resolving manufacturing issues
Anika Sharma
UCB’s long-awaited FDA approval for its psoriasis therapy, Bimzelx (bimekizumab), has finally arrived, ending a journey marked by manufacturing setbacks. ...
UCB’s psoriasis drug application overcomes manufacturing hurdle but hits another FDA delay
Anika Sharma
After facing delays related to manufacturing issues, UCB’s psoriasis medication, bimekizumab, is awaiting the next steps in its FDA review ...
UCB has achieved a long-awaited victory as the FDA grants approval for the myasthenia gravis drug Rystiggo
SG Tylor
Source – UCB On 27 June 2023, UCB faced regulatory challenges in the United States for the second consecutive year, ...
